|Bid||26.350 x 0|
|Ask||26.400 x 0|
|Day's Range||25.700 - 26.500|
|52 Week Range||18.880 - 27.600|
|PE Ratio (TTM)||15.60|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||25.12|
SHANGHAI/HONG KONG, Sept 23 (Reuters) - China's much-hyped market for vitamins and supplements is facing a steep challenge from traditional remedies from ginseng to deer antler, even as the sector's rise fuels billion-dollar deals and share price surges. It's being outstripped by a traditional medicine business that could be worth $40 billion by then - and is growing twice as fast.
Hong Kong-listed dietary supplements company Biostime International Holdings Ltd has agreed to buy Australian vitamin maker Swisse Wellness Pty Ltd for more than A$1.5 billion , Australian media reported ...
HONG KONG/SHANGHAI, July 24 (Reuters) - France's Danone SA is pulling the plug on efforts to revive its flagship Dumex infant formula unit in China on its own, swapping a business ravaged by food scares for a bigger stake in a domestic dairy giant as competition heats up in the world's biggest market for formula milk. The French food supplier said on Friday it has struck a "preliminary agreement" to sell its Dumex unit, once its top formula brand in China, to Yashili International Holdings Ltd . In return Danone will deepen ties with one of the country's biggest dairy firms, raising its 9.9 percent stake in China Mengniu Dairy Co Ltd, Yashili's indirect parent.